zumatek

ZumaTek, Inc. develops 3D dedicated imaging technologies for the lesion detection to treat breast cancer before it has formed a tumor or

ZumaTek, Inc. develops 3D dedicated imaging technologies for the lesion detection to treat breast cancer before it has formed a tumor or spread to lymph nodes. It develops devices that are used to monitor the progress of radiation therapy or chemotherapy in breast cancer patients as it is able to non-invasively detect chemical changes in the cancer cells. The company’s devices can also be combined with on-board biopsy or treatment devices. ZumaTek was incorporated in 2005 and is based in Chapel Hill, North Carolina.